If January is a sign of things to come for 2021, traders and investors are going to make a lot of money this year. 4 penny stocks on the move are Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSEMKT: IBIO), Solar Integrated Roofing (OTCMKTS: SIRC), and Tesoro Enterprises (OTCMKTS: TSNP).
HOW TO TRADE PENNY STOCKS
First up, it’s important to understand that trading penny stocks is not the same as trading blue chips. As we have stressed repeatedly to our subscribers, the key to trading penny stocks is finding momentum BEFORE it happens and then be patient.
Now, when we say that we find momentum BEFORE it happens, we are investors looking to position our subscribers BEFORE the move happens. We got our subscribers in early on TSNP, which you can read our first article here, and ENZC, which you can read about here. This is where the big money is made and why so many of our subscribers are sitting on gains of over 7750% in ENZC and over 36,150% in TSNP.
It’s also best to own a portfolio of quality penny stocks. For some that can be as many as 10 to 20 or more penny stocks.
We always alert our subscribers first before we publish for our regular readers. This is the value of having a subscription to Insider Financial, which you can sign up for here. We alert our subscribers with our best ideas before our regular readers.
Now we know many prefer to day trade, but we are not day traders here at Insider Financial. It doesn’t suit our personality and we don’t like the intraday moves markets make. We have found we made more money being patient and ignoring the day to day noise of the markets.
If you want to day trade, Insider Financial is not the place for you. When it comes to day trading, and if that’s what you are after, we recommend the folks at True Trading Group, which you can check out their live streams here.
OTC PENNY STOCKS VS NASDAQ/NYSE PENNY STOCKS
The fact is that there is always a bull market somewhere. That’s why it’s important for penny stock investors to trade both OTC and NASDAQ/NYSE penny stocks. There are always opportunities if you give yourself the flexibility to trade all markets.
Last year, for the first half of 2020, it was much more profitable to trade NASDAQ penny stocks than OTC. That is where we and our subscribers were positioned. We captured the runs in SRNE, NIO, INO, IBIO, WKHS, and many others. Then once the summer came, many of the COVID runners had failed to find momentum. We then pivoted to OTC and caught the runs in TSNP, ENZC, MMEDF, and many others.
So far this year, it’s best to play both OTC and NASDAQ/NYSE penny stocks. There is no shortage of multi-baggers in both markets at the moment. As we have said repeatedly, there’s no better time to be a penny stock trader and traders need to be aggressive. It’s like being at the casino. When you have a hot hand and the house keeps losing (hedge funds and institutions), take advantage of it while you can.
In this article, we take a look at 4 penny stocks on the move, AVXL, IBIO, SIRC, and TSNP to find out what’s behind the move and our outlook for each.
Penny Stock On The Move #1 AVXL
AVXL was a penny stock when we covered it last time, but not any longer. AVXL is running off the epic run in Cassava Sciences (NASDAQ: SAVA).
Investors are starting to wake up to the fact that AVXL is actually the better Alzheimer’s bet.
We said back in October that AVXL was ready to make a big move, which you can read here. We have said time and time again that ANAVEX2-73 is one of the most promising drugs in development.
Anavex’s lead asset ANAVEX®2-73 is currently undergoing a Phase 2b/3 study in Alzheimer’s disease. The enrollment was 80% complete, and full enrollment of 450 patients is expected in early 2021, the company announced in late December.
ANAVEX 2-73 is based on oxidation and nitration causing Alzheimer’s. Other drug companies have instead focused on the cause being amyloid. They have misdiagnosed the cause while we believe Anavex has the correct approach.
Anti-amyloid and anti-tau drugs have proven to only slightly slow down the progression of Alzheimer’s disease. The prevention or removal of either has shown little effect on the progression of the disease.
Inflammation, tau, and amyloid all add to oxidative stress but are themselves the products of this stress. The key then is not only to inhibit oxidative stress (which only moderately slows down the progression of the disease over time), but to remove compounds that are causing oxidation and nitration, and reverse part of the damage that they are doing to the brain.
Oxidation and nitration also likely play a role in Parkinson’s Disease Dementia and Rett syndrome. This is why we believe Anavex 2-73 is the most promising drug being developed today.
Cassava Sciences investors should consider selling SAVA and buying AVXL.
Penny Stock On The Move #2 IBIO
With all the tiny biotechs running, we see IBIO as the next big runner. As you can see from the chart below, IBIO hasn’t done much for the past six months. This could all be about to change very quickly.
We see IBIO as a turnaround play under new CEO Tom Isett. He has recruited Dr. Martin Brenner as IBIO’s Chief Scientific Officer. Dr. Brenner has a strong history of success heading drug discovery and development teams at several of the world’s leading pharmaceutical companies, including AstraZeneca, Eli Lilly, Pfizer, and Merck.
Most recently, Dr. Brenner served as the CSO at Pfenex Inc. that was acquired by Ligand Pharmaceuticals Incorporated for approximately $516 million in October 2020. Dr. Brenner knows how to groom small-cap biotechs to be bought out by big pharma. We can see the same happening with IBIO with its current market cap of just $461 million.
Penny Stock On The Move #3 SIRC
We talked about SIRC on December 29th when the stock was trading at just $.25 a share, which you can read here.
SIRC blasted through the $1 resistance level after announcing the official opening of operations of the Company’s dedicated electric vehicle (EV) charging solutions division, which is currently exploring the potential acquisition of several EV charger installers nationwide to expand the Company’s own Tesla-certified installer network.
According to a new Precedence Research report, the EV charging market size is set to surpass the $39 Billion mark by 2027, growing at a 40% rate from 2020 through 2027.
“We are excited to have entered the substantial, growing EV charging space – addressing an incredible, rapidly emerging market opportunity,” said David Massey, Chief Executive Officer of Solar Integrated Roofing Corporation. “We are well-positioned to acquire promising EV charger installers in key growth markets across the U.S. where early EV adoption has been greatest. I look forward to announcing further developments on this front as we continue our rapid pace of operational execution, creating long-term value for our shareholders.”
SIRC’s primary focus within the EV charging vertical will remain the sales, marketing, installation, and service of personal EV chargers at residential properties, as well as on public EV charging infrastructure for network operators – leveraging the Company’s recent designation as a Tesla-certified installer.
Solar Integrated Roofing is also exploring the potential acquisition of various EV charging installers nationwide, addressing a rapidly growing domestic EV market – with some states such as California setting aggressive regulatory targets of all new vehicle sales to be zero emissions by 2035.
SIRC is growing rapidly after recording $5.2 million in revenues in the latest quarter. This growth will continue as the company benefits from the upcoming green energy policies from the new Biden/Harris administration.
Penny Stock On The Move #4 TSNP
TSNP just won’t quit. We have covered TSNP extensively here at Insider Financial starting in November when the stock was trading at just $.0008 a share and which you can read here. You can look at our full lineup of coverage here and can see that we have been bullish every step of the way.
Now we know many of you don’t have shares at $.0008; however, we have been saying time and time again with our articles and videos that the key was to buy the red day dips on TSNP. Every pullback has been an opportunity to load up before the next move higher. Matter of fact, we told everyone just last weekend to load up on TSNP, which you can watch below.
TSNP is running for a few reasons.
One, HUMBL just launched its BLOCK Exchange Traded Index (ETXs) lineup in over one hundred countries across North America, Latin America, Asia, Middle East, Africa, and the Caribbean.
HUMBL Financial products are now available to customers in Albania, Algeria, Andorra, Angola, Anguilla, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Barbados, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Cameroon, Canada, Cape Verde, Cayman Islands, Chad, China, Chile, Columbia, Comoros, Cook Islands, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Ecuador, El Salvador, Estonia, Falkland Islands Malvinas, Faroe Islands, Fiji, Finland, France, French Polynesia, Gabon, Gambia, Georgia, Germany, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guatemala, Holy See Vatican City, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Korea (South), Kuwait, Kyrgyzstan, Latvia, Lesotho, Liechtenstein, Lithuania, Luxembourg, Macedonia, Madagascar, Malawi, Malaysia, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Namibia, Nepal, Netherlands, New Caledonia, New Zealand, Niger, Nigeria, Niue, Norfolk Island, Norway, Oman, Palau, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Qatar, Reunion, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Pierre and Miquelon, Saint Vincent and the Grenadines, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, South Africa, Spain, Suriname, Swaziland, Sweden, Switzerland, Taiwan, Tajikistan, Tanzania, Thailand, Togo, Tonga, Turkmenistan, Turks and Caicos Islands, United Arab Emirates, United Kingdom, Uruguay, Vietnam, British Virgin Islands, Wallis and Futuna and Zambia.
The initial BLOCK ETXs include the: BLOCK 3, BLOCK 5, BLOCK 10, BLOCK Government, BLOCK Platform, BLOCK Global Enterprise, BLOCK RSI Fractals, BLOCK MACD & VI, and BLOCK Oscillators.
The BLOCK ETX lines were created by HUMBL Financial to give retail investors access to “one-click” software services on the new digital asset trading markets. The BLOCK ETXs track three different vertical themes: Index, Active and Thematic strategies, allowing customers simplified portfolio exposure to new blockchain trading markets.
HUMBL Financial is also open to the licensing of BLOCK Indexes and BLOCK ETXs to major, global financial institutions that may want to expand their digital asset offerings for customers immediately.
Two, we believe that a major short is getting squeezed in TSNP just like in GameStop. This Seeking Alpha short and distort attack was posted on December 14th when TSNP was just $.17 a share. TSNP had a market cap of just $662 million at the time the article was posted. TSNP’s current market cap is now $2.5 billion.
These 4 penny stocks are hot right now. There are always opportunities in the markets and it’s our job to find winning stocks. Huge gains can be made in such a short amount of time.
Our best advice is to be patient and throw bids in below the market. Buying dips and selling rips as swing trades remains the best strategy in these markets.
Remember, all it takes is one or two to become an AVXL, IBIO, SIRC, or TSNP and you’ve crushed the market indices for the year. Whoever said to avoid penny stocks has no clue what they’re doing.
As always, good luck to all (except the shorts)!
WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN FINDING MOMENTUM BEFORE IT HAPPENS!
Disclosure: We have no position in any of the securities mentioned. We wrote this article ourselves and it expresses our own opinions. We are not receiving compensation for it. We have no business relationship with any company whose stock is mentioned in this article. Insider Financial is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This article is not a solicitation or recommendation to buy, sell, or hold securities. This article is meant for informational and educational purposes only and does not provide investment advice.